Cytomegalovirus and atherogenesis

Antiviral Research

Volumn 43, Issue 3, 1999, Pages 135-144

  Bruggeman, Cathrien A ^a   Marjorie, H J ^a   Nelissen Vrancken, G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherogenesis; Atheroxclerosis; chronic infection; Cytomegalovirus; Latency

Indexed keywords

ARTERIOSCLEROSIS; ATHEROGENESIS; BLOOD VESSEL WALL; CELL MIGRATION; CELL PROLIFERATION; CYTOMEGALOVIRUS; ENDOTHELIUM CELL; ENDOTHELIUM LESION; HUMAN; LIPID METABOLISM; NONHUMAN; ORGAN TRANSPLANTATION; PATHOGENESIS; PRIORITY JOURNAL; RESTENOSIS; REVIEW; VIRUS INFECTION;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; ARTERIOSCLEROSIS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; ORGAN TRANSPLANTATION;

EID: 0032862046     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00051-0     Document Type: Review

References (81)

1. Adam E., Melnick J.L., Probtsfield J.L., Petrie B.L., Burek J., Bailey K.R., McCollum C.H., DeBakey M.E. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet. 2:1987;291-293.
2. Adler S.P., Hur J.K., Wang J.B., Wang G.W.V. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J. Infect. Dis. 177:1998;209-212.
3. Almeida G.D., Porada C.D., St Jeor S., Ascensao J.L. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood. 83:1994;370-376.
4. Beisser P.S., Vink C., VanDam J.G., Grauls G., Vanherle S.J.V., Bruggeman C.A. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. J. Virol. 72(3):1998;2352-2363.
5. Benditt E.P., Benditt J.M. Evidence for monoclonal origin of human atherosclerotic plaques. Proc. Natl. Acad. Sci. USA. 70:1973;1753-1756.
6. Berencsi K., Endresz V., Klurfeld D., Kari L., Kritchevsky D., Gonczol E. Early atherosclerotic plaques in the aorta following cytomegalovirus infection of mice. Cell Adhesion Comm. 5(1):1998;39-47.
7. Bruggeman C.A., van Dam Mieras M.C. The possible role of cytomegalovirus in atherogenesis. Prog. Med. Virol. 38:1991;1-26.
8. Bruning J.H., Persoons M., Lemstrom K., Stals F.S., Clerq de E., Bruggeman C.A. Enhancement of transplantation-associated athererosclerosis by CMV, which can be prevented by anti viral therapy in the form of HPMPC. Transplant Int. 7:1994;S365-S370.
9. Chiu B., Viira E., Tucker W., Fong I.W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation. 96:1997;2144-2148.
10. Craigen J.L., Grundy J.E. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation. 62:1996;1102-1108.
11. Danesh J., Collins R., Peto R. Chronic infections and coronary heart disease: is there a link? [see comments]. Lancet. 350:1997;430-436.
12. Dangler C.A., Baker S.E., Kariuki Njenga M., Chia S.H. Murine cytomegalovirus-associated arteritis. Vet Pathol. 32:1995;127-133.
13. Epstein S.E., Speir E., Zhou Y.F., Guetta E., Leon M., Finkel T. The role of infection in restenosis and atherosclerosis: focus on cytomegalovirus. Lancet 348 Suppl. 1:1996;13-17.
14. Fabricant C.G. Atherosclerosis: the consequence of infection with a herpesvirus. Adv. Vet. Sci. Comp. Med. 30:1985;39-66.
15. Fabricant C.G., Fabricant J., Litrenta M.M., Minick C.R. Virus-induced atherosclerosis. J. Exp. Med. 148:1978;335-340.
16. Fabricant C.G., Hajjar D.P., Minick C.R., Fabricant J. Herpesvirus infection enhances cholesterol and cholesteryl ester accumulation in cultured arterial smooth muscle cells. Am. J. Pathol. 105:1981;176-184.
17. Fabricant C.G., Krook L., Gillespie J.H. Virus-induced cholesterol crystals. Science. 181:1973;566-567.
18. Gao J.L., Murphy P.M. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. J. Biol. Chem. 269:1994;28539-28542.
19. Gompels U.A., Nicholas J., Lawrence G., Jones M., Thomson B.J., Martin M.E., Efstathiou S., Craxton M., Macaulay H.A. The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology. 209:1995;29-51.
20. Grattan M.T., Moreno Cabral C.E., Starnes V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. J. Am. Med. Assoc. 261:1989;3561-3566.
21. Grundy J.E. Current antiviral therapy fails to prevent the pro-inflammatory effects of cytomegalovirus infection, whilst rendering infected cells relatively resistant to immune attack. Mongraphs Virol. 21:1998;67-89.
22. Hajjar D.P., Fabricant C.G., Minick C.R., Fabricant J. Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am. J. Pathol. 122:1986;62-70.
23. Hayry P., Mennander A., Raisanen A., Ustinov J., Lemstrom K., Aho P., Yilmaz S., Lautenschlager I., Paavonen T. Pathophysiology of vascular wall changes in chronic allograft rejection. Transplant. Rev. 7:1993;1-20.
24. Hendrix M.G., Daemen M., Bruggeman C.A. Cytomegalovirus nucleic acid distribution within the human vascular tree. Am. J. Pathol. 138:1991;563-567.
25. Hendrix M.G., Dormans P.H., Kitslaar P., Bosman F., Bruggeman C.A. The presence of cytomegalovirus nucleic acids in arterial walls of atherosclerotic and nonatherosclerotic patients. Am. J. Pathol. 134:1989;1151-1157.
26. Hendrix M.G., Salimans M.M., van Boven C.P., Bruggeman C.A. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am. J. Pathol. 136:1990;23-28.
27. Hruban R.H., Wu T.C., Beschorner W.E., Cameron D.E., Ambinder R.F., Baumgartner W.A., Reitz B.A., Hutchins G.M. Cytomegalovirus nucleic acids in allografted hearts [letter]. Hum. Pathol. 21:1990;981-982.
28. Jacobson M.A. Treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome. New Engl. J. Med. 337:1997;105-114.
29. Kol A., Libby P. The mechanisms by which infectious agents may contribute to atherosclerosis and its clinical manifestations. Trends Cardiovasc. Med. 8(5):1998;191-199.
30. Koskinen P., Lemstrom K., Bruggeman C., Lautenschlager I., Hayry P. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Am. J. Pathol. 144:1994;41-50.
31. Lee J.Y. Cytomegalovirus infection involving the skin in immunocompromised hosts. A clinicopathologic study. Am. J. Clin. Pathol. 92:1989;96-100.
32. Lemstrom K.B., Bruning J.H., Bruggeman C.A., Lautenschlager I.T., Hayry P.J. Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts. J. Clin. Invest. 92:1993;548-549.
33. Lemstrom K.B., Aho P.T., Bruggeman C.A., Hayry P.J. Cytomegalovirus infection enhances mRNA expression of platelet-derived growth factor-BB and transforming growth factor-beta 1 in rat aortic allografts. Possible mechanism for cytomegalovirus-enhanced graft arteriosclerosis. Arterioscler. Thromb. 14:1994;2043-2052.
34. Lemstrom K.B., Bruning J.H., Bruggeman C.A., Koskinen P.K., Aho P.T., Yilmaz S., Lautenschlager I.T., Hayry P.J. Cytomegalovirus infection-enhanced allograft arteriosclerosis is prevented by DHPG prophylaxis in the rat. Circulation. 90:1994;1969-1978.
35. Lemstrom K.B., Bruning J.H., Bruggeman C.A., Lautenschlager I.T., Hayry P.J. Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection. Am. J. Pathol. 144:1994;1334-1347.
36. Li F., Yin M., Van Dam J., Grauls G., Rozing J., Bruggeman C. Cytomegalovirus infection enhances the neointima formation in rat aortic allograft. Transplantation. 65:1998;1298-1304.
37. Li F.L., Grauls G., Yin M., Bruggeman C.A. Correlation between the intensity of cytomegalovirus infection and the amount of perivasculitis in aortic allografts. Transpl. Int. 9 Suppl. 1:1996;S340-S344.
38. Libby P., Ergan D., Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. An assessment of the evidence and need for future research. Circulation. 96:1997;4095-4103.
39. Loebe M., Schuler S., Spiegelsberger S., Warnecke H., Fleck E., Hetzer R. Cytomegalovirus infection and coronary sclerosis after heart transplantation] Cytomegalievirus-Infektion und Koronarsklerose nach Herztransplantation. Dtsch. Med. Wochenschr. 115:1990;1266-1269.
40. McDonald K., Rector T.S., Braulin E.A., Kubo S.H., Olivari M.T. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am. J. Cardiol. 64:1989;359-362.
41. Melnick J.L., Adam E., DeBakey M.E. Possible role of cytomegalovirus in atherogenesis. J. Am. Med. Assoc. 263:1990;2204-2207.
42. Melnick J.L., Adam E., DeBakey M.E. Cytomegalovirus and atherosclerosis. Bioessays. 17:1995;899-903.
43. Melnick J.L., Hu C., Burek J., Adam E., DeBakey M.E. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J. Med. Virol. 42:1994;170-174.
44. Melnick J.L., Petrie B.L., Dreesman G.R., Burek J., McCollum C.H., DeBakey M.E. Cytomegalovirus antigen within human arterial smooth muscle cells. Lancet. 2:1983;644-647.
45. Minick C.R., Fabricant C.G., Fabricant J., Litrenta M.M. Atheroarteriosclerosis induced by infection with a herpesvirus. Am. J. Pathol. 96:1979;673-706.
46. Murayama T., Mukaida N., Khabar K.S.A., Matsushima K. Potential involvement of IL-8 in the pathogenesis of human cytomegalovirus infection. J. Leuk. Biol. 64(1):1998;62-67.
47. Myerson D., Hackman R.C., Nelson J.A., Ward D.C., McDougall J.K. Widespread presence of histologically occult cytomegalovirus. Hum. Pathol. 15:1984;430-439.
48. Nelissen-Vrancken, H.J.M.G., Koch, R.H.P.W., Vliegen, I., Grauls, G.E.L.M., Daemen, M.J.A.P. Bruggeman, C.A. (1999) Cytomegalovirus (CMV) accelerates the development of atherosclerosis in apolipoprotein E-deficient mice., FASEB J (in press).
49. Nicholson A.C., Hajjar D.P. Herpesviruses in atherosclerosis and thrombosis - Etiologic agents or ubiquitous bystanders. Arterioscler. Thrombosis Vasc. Biol. 18(3):1998;339-348.
50. Nieto F.J., Adam E., Sorlie P., Farzadegan H., Melnick J.L., Comstock G.W., Szklo M. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis [see comments]. Circulation. 94:1996;922-927.
51. Nieto F.J., Sorlie P., Comstock G.W., Wu K., Adam E., Melnick J.L., Szklo M. Cytomegalovirus infection, lipoprotein(a), and hypercoagulability: an atherogenic link? Arterioscler. Thromb. Vasc. Biol. 17:1997;1780-1785.
52. Persoons M.C.J., Daemen M.J.A.P., Bruning J.H., Bruggeman C.A. Active cytomegalovirus of arterial smooth muscle cells in immunocompromised rats. A clue to herpesvirus- associated atherogenesis? Circulat. Res. 75:1994;214-220.
53. Persoons, M.C.J., Daemen, M.J.A.P., Van Kleef, E.M., Grauls, G.E.L.M., Bruggeman, C.A. (1999) Rat muscle cells in vivo are not susceptible to active cytomegalovirus infection, (submitted).
54. Persoons M.C.J., Daemen M.J.A.P., Van Kleef E.M., Grauls G.E.L.M., Wijers E., Bruggeman C.A. Neointimal smooth muscle cell phenotype is important in its susceptibility to cytomegalovirus (CMV) infection: a study in rat. Cardiovasc. Res. 36:1997;282-288.
55. Persoons M.C.J., Stals F.S., Dam-Mieras M.C.E., Bruggeman C.A. Multiple organ involvement during experimental cytomegalovirus infection is associated with disseminated vascular pathology. J. Pathol. 184:1998;103-109.
56. Presti, R.M., Pollock, J.L., DalCanto, A.J., AK, O.G., Virgin, H.W., 1998. Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels, J. Exp. Med. 188 (3), 577-588.
57. Ridker P.M., Hennekens C.H., Stampfer M.J., Wang F. Prospective study of herpes simplex virus, cytomegalovirus, and the risk of future myocardial infarction and stroke. Circulation. 98(25):1998;2796-2799.
58. Ross R. The pathogenesis of atherosclerosis: a perspective from the 1990's. Nature. 362:1993;801-809.
59. Safrin S., Cherrington J., Jaffe H.S. Clinical uses of cidofovir. Rev. Med. Virol. 7:1997;145-156.
60. Scholz M., Cinatl J., Gross V., Vogel J.U., Blaheta R.A., Freisleben H.J., Markus B.H., Doerr H.W. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells. Transplantation. 61:1996;1763-1770.
61. Slobbe van Drunen M.E., Vossen R.C., Couwenberg F.M., Hulsbosch M.M., Heemskerk J.W., van Dam Mieras M.C., Bruggeman C.A. Activation of protein kinase C enhances the infection of endothelial cells by human cytomegalovirus. Virus Res. 48:1997;207-213.
62. Sorlie P.D., Adam E., Melnick S.L., Folsom A., Skelton T., Chambless L.E., Barnes R., Melnick J.L. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC Study. J. Med. Virol. 42:1994;33-37.
63. Span A.H., Frederik P.M., Grauls G., Van Boven G.P., Bruggeman C.A. CMV induced vascular injury: an electron-microscopic study in the rat. In Vivo. 7:1993;567-573.
64. Span A.H., Grauls G., Bosman F., van Boven C.P., Bruggeman C.A. Cytomegalovirus infection induces vascular injury in the rat. Atherosclerosis. 93:1992;41-52.
65. Span A.H., Mullers W., Miltenburg A.M., Bruggeman C.A. Cytomegalovirus induced PMN adherence in relation to an ELAM-1 antigen present on infected endothelial cell monolayers. Immunology. 72:1991;355-360.
66. Speir E., Modali R., Huang E.S., Leon M.B., Shawl F., Finkel T., Epstein S.E. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis [see comments]CM: Comment in: Science 1994 Jul 15;265(5170):320. Science. 265:1994;391-394.
67. Tanaka S., Komori K., Okadome K., Sugimachi K., Mori R. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J. Vasc. Surg. 20:1994;235-243.
68. Tumilowicz J.J., Gawlik M.E., Powell B.B., Trentin J.J. Replication of cytomegalovirus in human arterial smooth muscle cells. J. Virol. 56:1985;839-845.
69. van Dam Mieras M.C., Muller A.D., van Hinsbergh V.W., Mullers W.J., Bomans P.H., Bruggeman C.A. The procoagulant response of cytomegalovirus infected endothelial cells. Thromb. Haemost. 68:1992;364-370.
70. van Geelen A.G., Slobbe van Drunen M.E., Muller A.D., Bruggeman C.A., Van Dam Mieras M.C. Membrane related effects in endothelial cells induced by human cytomegalovirus. Arch. Virol. 140:1995;1601-1612.
71. Vossen R.C., Derhaag J.G., Slobbe van Drunen M.E., Duijvestijn A.M., van Dam Mieras M.C., Bruggeman C.A. A dual role for endothelial cells in cytomegalovirus infection? A study of cytomegalovirus infection in a series of rat endothelial cell lines. Virus Res. 46:1996;65-74.
72. Vossen R.C.R.M., Persoons M.C.J., Slobbe-van Drunen M.E.P., Bruggeman C.A. Intracellular thiol redox status affects cytomegalovirus infection of vascular cells. Virus Res. 48:1997;173-183.
73. Waldman W.J., Sneddon J.M., Stephens R.E., Roberts W.H. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J. Med. Virol. 28:1989;223-230.
74. Wilcox C.M., Diehl D.L., Cello J.P., Margaretten W., Jacobson M.A. Cytomegalovirus esophagitis in patients with AIDS. A clinical, endoscopic, and pathologic correlation. Ann. Intern. Med. 113:1990;589-593.
75. Woodroffe S.B., Garnett H.M., Danis V.A. Interleukin-1 production and cell-activation response to cytomegalovirus infection of vascular endothelial cells. Arch. Virol. 133:1993;295-308.
76. Yamashiroya, H.M., Ghosh, L., Yang, R. and Robertson, A.L., Jr. (1988) Herpesviridae in the coronary arteries and aorta of young trauma victims, Am J Pathol 130, 71-9.
77. Yonemitsu Y., Nakagawa K., Tanaka S., Mori R., Sugimachi K., Sueishi K. In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. Lab Invest. 74:1996;723-736.
78. Zhang S.H., Reddick R.L., Piedrahita J.A., Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.
79. Zhou Y.F., Guetta E., Yu Z.X., Finkel T., Epstein S.E. Human cytomegalovirus increases modified low density lipoprotein uptake and scavenger receptor mRNA expression in vascular smooth muscle cells. J. Clin. Invest. 98:1996;2129-2138.
80. Zhou, Y.F., Shou, M., Guzman, R., Guetta, E., Finkel, T. Epstein, G.E. (1995) Cytomegalovirus infection increases neointimal formation in the rat model of balloon injury, JACC 25, abstract.
81. Zhu H., Shen Y., Shenk T. Human cytomegalovirus IE1 and IE2 proteins block apoptosis. J. Virol. 69:1995;7960-7970.